Management of Complex Ovarian Cysts

Initial Diagnostic Approach

The American College of Radiology's O-RADS system provides a clear treatment pathway for managing complex ovarian cysts, with a risk-stratified approach based on ultrasound characteristics, menopausal status, and size 1, 2, 3
Transvaginal ultrasound is the essential imaging modality to characterize the mass and differentiate simple, complex, or solid components, with features such as solid papillary projections, irregular internal septations, or ascites being highly suggestive of malignancy 2, 4, 5
Serum CA-125 should be measured before any intervention, with elevated levels occurring in 50% of stage I disease and 85% of advanced disease, although false positives can occur with endometriosis, pelvic inflammatory disease, and menstruation 1, 4, 5

For O-RADS 1-2, conservative management with observation only is recommended, with no intervention required 3
For O-RADS 3, management by a general gynecologist with ultrasound specialist consultation or MRI examination is recommended to minimize the risk of overlooking suspicious features 3
For O-RADS 4, gynecologic oncology consultation prior to any surgical intervention is necessary 3
For O-RADS 5, direct referral to a gynecologic oncologist is required, with no attempt at surgery without oncology involvement 3

In premenopausal women, cysts ≤5 cm require no management, while cysts >5 cm but <10 cm require follow-up ultrasound in 8-12 weeks, and cysts >10 cm require surgical management regardless of characteristics 2, 3
In postmenopausal women, purely fluid cysts >5 cm must be followed by ultrasonography or excised by a gynecological surgeon 1

Fine-needle aspiration for cytological examination of solid or mixed ovarian masses is absolutely contraindicated, with a risk of non-informative cytology of 25% and recurrence risk of 20% 1, 2, 3
Transvaginal aspiration is contraindicated for purely fluid cysts >5 cm in postmenopausal women, which must be followed or surgically excised 1, 2, 3

Surgical exploration via midline laparotomy is necessary for definitive staging when malignancy is suspected, with preoperative CT scanning not useful for staging and MRI only helpful when surgical management would change based on involvement of rectosigmoid, bladder, or pelvic wall 1
In premenopausal women requiring surgery, fertility-sparing procedures should be prioritized when appropriate 6

NSAIDs, such as naproxen 500-550 mg orally or ketorolac 20 mg orally, are first-line for ovarian cyst pain, always taken with food to prevent gastric irritation 3

Failing to perform adequate follow-up for cysts >5 cm, which require complete evaluation 3
Unnecessary surgical intervention for simple cysts, which are vast majority benign even in postmenopausal women 3
Attempting aspiration of complex masses, which provides no diagnostic benefit and risks complications 1
Operating without oncology consultation when O-RADS ≥4, which requires specialized surgical staging 3

Unexplained weight loss in women >50 years requires urgent evaluation for possible malignancy 2

The American College of Radiology recommends transvaginal ultrasound as the essential first‑line imaging technique to differentiate simple from complex ovarian cysts, a distinction that drives all subsequent management decisions in premenopausal women. 7

The American College of Radiology advises that transvaginal ultrasound examinations include color or power Doppler imaging to distinguish true solid components from debris, evaluate vascular patterns, and confirm the ovarian origin of the mass. 7

According to the American College of Radiology, a comprehensive ultrasound report should describe wall thickness, the number and thickness of septations, presence of solid components, papillary projections, any associated ascites, and the pattern of vascularity, as these features are critical for risk stratification. 7

The American College of Radiology identifies specific sonographic appearances that allow confident benign diagnosis:
- Hemorrhagic cysts – “spider‑web” appearance or retracting clot with peripheral vascularity.
- Endometriomas – low‑level internal echoes, mural echogenic foci, or non‑vascular solid‑attenuating components.
- Dermoid (mature cystic teratoma) cysts – echogenic attenuating component or small horizontal interfaces.
- Hydrosalpinx – tubular cystic mass with or without characteristic folds.